Correlation Between Korean Drug and SDN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Korean Drug and SDN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and SDN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korean Drug Co and SDN Company, you can compare the effects of market volatilities on Korean Drug and SDN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of SDN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and SDN.

Diversification Opportunities for Korean Drug and SDN

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Korean and SDN is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and SDN Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SDN Company and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with SDN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SDN Company has no effect on the direction of Korean Drug i.e., Korean Drug and SDN go up and down completely randomly.

Pair Corralation between Korean Drug and SDN

Assuming the 90 days trading horizon Korean Drug Co is expected to generate 0.38 times more return on investment than SDN. However, Korean Drug Co is 2.63 times less risky than SDN. It trades about -0.16 of its potential returns per unit of risk. SDN Company is currently generating about -0.11 per unit of risk. If you would invest  508,000  in Korean Drug Co on September 14, 2024 and sell it today you would lose (63,000) from holding Korean Drug Co or give up 12.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Korean Drug Co  vs.  SDN Company

 Performance 
       Timeline  
Korean Drug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
SDN Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SDN Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Korean Drug and SDN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Korean Drug and SDN

The main advantage of trading using opposite Korean Drug and SDN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, SDN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SDN will offset losses from the drop in SDN's long position.
The idea behind Korean Drug Co and SDN Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.